REAL LIFE USE OF ANTITHROMBOTIC TREATMENT IN ATRIAL FIBRILLATION: INSIGHTS FROM THE INTERNATIONAL REALISEAF REGISTRY

被引:0
作者
Gamra, Habib [1 ]
Silva-Cardoso, Jose [1 ]
Murin, Jan [1 ]
O'Neill, James [1 ]
Chiang, Chern-En [1 ]
Merioua, Ihsen [1 ]
Naditch-Brule, Lisa [1 ]
Steg, Philippe Gabriel [1 ]
机构
[1] Fattouma Bourguiba Univ Hosp, Monastir, Tunisia
关键词
D O I
10.1016/S0735-1097(11)61152-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E1152 / E1152
页数:1
相关论文
共 50 条
  • [21] Impact of renal function on use of antithrombotic therapy in atrial fibrillation: real-world perspective from the global anticoagulant registry in the FIELD registry
    Goto, S.
    Lip, G. Y. H.
    Goldhaber, S. Z.
    Verheugt, F. W. A.
    Bassand, J. P.
    Turpie, A. G. G.
    Mueller, I.
    Rushton-Smith, S.
    Kakkar, A. K.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 967 - 968
  • [22] Risk Profiles and Antithrombotic Treatment of Patients With Atrial Fibrillation in China: China Registry of Atrial Fibrillation (CRAF)
    Sun, Yihong
    Hu, Dayi
    [J]. CIRCULATION, 2013, 128 (22)
  • [23] Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry
    Despoina-Rafailia Benetou
    Charalampos Varlamos
    Dionysios Ktenas
    Ioannis Tsiafoutis
    Michael Koutouzis
    Theodora Bampali
    Christos Mantis
    John Zarifis
    Emmanouil Skalidis
    Dionysios Aravantinos
    Dimitrios Varvarousis
    Ioannis Lianos
    John Kanakakis
    Evangelos Pisimisis
    Antonios Ziakas
    Periklis Davlouros
    Dimitrios Alexopoulos
    [J]. Cardiovascular Drugs and Therapy, 2021, 35 : 11 - 20
  • [24] Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry
    Benetou, Despoina-Rafailia
    Varlamos, Charalampos
    Ktenas, Dionysios
    Tsiafoutis, Ioannis
    Koutouzis, Michael
    Bampali, Theodora
    Mantis, Christos
    Zarifis, John
    Skalidis, Emmanouil
    Aravantinos, Dionysios
    Varvarousis, Dimitrios
    Lianos, Ioannis
    Kanakakis, John
    Pisimisis, Evangelos
    Ziakas, Antonios
    Davlouros, Periklis
    Alexopoulos, Dimitrios
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (01) : 11 - 20
  • [25] Antithrombotic treatment in atrial fibrillation
    Borja, J
    García, O
    Izquierdo, I
    [J]. EXPERT OPINION ON DRUG SAFETY, 2006, 5 (04) : 485 - 486
  • [26] Patterns of antithrombotic therapy and type of atrial fibrillation: insights from the Global Anticoagulant Registry in the FIELD (GARFIELD)
    Lip, G. Y. H.
    Rushton-Smith, S. K.
    Goto, S.
    Verheugt, F. W. A.
    Goldhaber, S. Z.
    Haas, S.
    Bassand, J. P.
    Mueller, I.
    Kakkar, A. K.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 54 - 54
  • [27] Antithrombotic treatment in atrial fibrillation
    Bereznicki, Luke R.
    Peterson, Gregory M.
    Jackson, Shane L.
    Jeffrey, Ella C.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2006, 5 (05) : 597 - 597
  • [28] Antithrombotic treatment in atrial fibrillation
    Lip, G. Y. H.
    Boos, C. J.
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2008, 84 (991) : 252 - 258
  • [29] Antithrombotic treatment in atrial fibrillation
    Kalra, L.
    Lip, G. Y. H.
    [J]. HEART, 2007, 93 (01) : 39 - 44
  • [30] Antithrombotic treatment in atrial fibrillation
    Lip, GYH
    Boos, CJ
    [J]. HEART, 2006, 92 (02) : 155 - 161